Differential effects of corticosteroids during different stages of dendritic cell maturation

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1233-1242

  Matyszak, Malgosia K ^a   Citterio, Stefania ^a   Rescigno, Maria ^a   Ricciardi Castagnoli, Paola ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Corticosteroid; Dendritic cell; IL 10; T suppressor cell

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL LINE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; EFFECTOR CELL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADRENAL CORTEX HORMONES; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DEXAMETHASONE; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 0033998582     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F     Document Type: Article

References (40)

1. Rescigno, M., Granucci, F., Citterio, S., Foti, M. and Ricciardi-Castagnoli, P., Coordinated events during bacteria-induced DC maturation, Immunol. Today 1999. 20: 200-203.
2. Steinman, R. M., The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991. 9: 271-296.
3. Rescigno, M., Granucci, F. and Ricciardi-Castagnoli, P., Dendritic cells at the end of the Millennium. Immunol. Cell Biol. 1999. 77: 404-410.
4. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J. and Ricciardi-Castagnoli, P., Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 1997. 185: 317-328.
5. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
6. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
7. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
8. Beck, R. W., Cleary, P. A., Trobe, J. D., Kaufman, D. I., Kupersmith, M. J., Paty, D. W. and Brown, C. H., The effect of cortico-steroids for acute optic neuritis on the subsequent development of multiple sclerosis. N. Engl. J. Med. 1993. 329: 1764-1769.
9. MacPhee, I. A., Antoni, F. A. and Mason, D. W., Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989. 169: 431-445.
10. Lee, S. W., Tsou, A. P., Chan, H., Thomas, J., Petrie, K. and Eugui, E. M., Glucocorticoids selectively inhibit the transcription of the interleukin 1b gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. USA 1988. 85: 1204-1210.
11. Waage, A., Slupphaug, G. and Shalaby, R., Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblast. Eur. J. immunol. 1990. 20: 2439-2443.
12. Beutler, B., Krochin, N., Milsark, I. W., Luedke, C. and Cerami, A., Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 1986. 232: 977-980.
13. Fushimi, T., Okayama, H., Seki, T., Shimura, S. and Shirato, K., Dexamethasone suppressed gene expression and production of IL-10 by human peripheral blood mononuclear cells and monocytes. Int. Arch. Allergy Immunol. 1997. 112: 13-18.
14. Blotta, M. H., DeKruyff, R. H. and Umetsu, D. T., Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 1997. 158: 5589-5595.
15. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, A. S. J., Role of transcriptional activation of IxB alpha in mediation of immunosuppression of glucocorticoids. Science 1995. 270: 283-286.
16. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M., Immunosuppression of glucocorticoids:inhibition of NF-xB activity through induction of I kappa B synthesis. Science 1995. 270: 286-290.
17. Wu, C. Y, Fargeas, C., Nakajima, T. and Delespesse, G., Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 1991. 21: 2645-2647.
18. Ramirez, F., Fowell, D. J., Puklavec, M., Simmonds, S. and Mason, D., Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 1996. 156: 2406-2412.
19. Leung, D. Y. M., Martin, R. J., Szefler, S. J., Sher, E. R., Ying, S., Kay, A. B. and Hamid, Q., Dysregulation of interleukin-4, interleukin 5 and interferon g gene expression in steroid-resistant asthma. J. Exp. Med. 1995. 181: 33-40.
20. Fokkens, W. J., Godthelp, T., Holm, A. F., Blom, H. and Klein-Jan, A., Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy. Allergy 1997. 52: 29-32.
21. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
22. Moser, M., De Smedt, T., Sornasse, T., Tielemans, F., Chentoufi, A. A., Muraille, E., Van Mechelen, M., Urbain, J. and Oberdan, L., Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 1995. 25: 2818-2824.
23. Piemonti, L., Monti, P., Allavena, P., Sironi, M., Soldini, L., Leone, B. E., Socci, C. and Di Carlo, V., Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 1999. 162: 6473-6481.
24. Vieira, P. L., Kalinski, P., Wierenga, E. A., Kapsenberg, M. L. and de Jong, E. C., Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 1998. 161: 5245-5251.
25. Wandinger, K. P., Wessel, K., Trillenberg, P., Heindl, N. and Kirchner, H., Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients. Acta Neurol. Scand. 1998. 97: 359-365.
26. Matyszak, M. K. and Perry, V. H., Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metallproteinases. J. Neuroimmunol. 1996. 69: 141-149.
27. Crofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P. and Wilder, R. L., Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. 1992. 90: 2555-2564.
28. DeKruyff, R. H., Fang, Y. and Umetsu, D. T., Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 1998. 160: 2231-2237.
29. de Vries, J. E., Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 1995. 27: 537-541.
30. Herfarth, H. H., Bocker, U., Janardhanam, R. and Sartor, R. B., Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats. Gastroenterology 1998. 115: 856-865.
31. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lyrnphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
32. Rott, O., Fleischer, B. and Cash, E., Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994. 24: 1434-1440.
33. Willenborg, D. O., Fordham, S. A., Cowden, W. B. and Ramshaw, I. A., Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 1995. 41: 31-41.
34. Segal, B. M., Dwyer, B. K. and Shevach, E. M., An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998. 187: 537-546.
35. Kennedy, M. K., Torrance, D. S., Picha, K. S. and Mohler, K. M., Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992. 149: 2496-2505.
36. Buelens, C., Verhasselt, V., DeGroote, D., Thielemans, K., Goldman, M. and Williams, F., Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/ macrophage-colony-stimulating factor. Eur. J. Immunol. 1997. 27: 756-762.
37. Buelens, C., Willems, F., Delvax, A., Pierard, G., Delville, J. P., Velu, T. and Goldman, M., Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 1995. 25: 2668-2672.
38. Enk, A., Angeloni, V. L., Udey, M. C. and Katz, S. I., Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 1993. 151: 2390-2398.
39. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997. 159: 4772-4780.
40. Citterio, S., Rescigno, M., Foti, M., Granucci, F., Matyszak, M. K., Girolomoni, G. and Ricciardi-Castagnoli, P., Generation of mouse dendritic cell lines. Methods 1999. 19: 142-147.